Cost-effectiveness of five versus ten years of alendronate treatment prior to drug holiday for women with osteoporosis

被引:0
作者
S. Nayak
S. L. Greenspan
机构
[1] Berkeley Madonna,School of Medicine
[2] Inc.,undefined
[3] University of Pittsburgh,undefined
来源
Osteoporosis International | 2020年 / 31卷
关键词
Alendronate; Bisphosphonates; Cost-effectiveness analysis; Drug holiday; Osteoporosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1273 / 1282
页数:9
相关论文
共 248 条
[1]  
Wright NC(2014)The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine J Bone Miner Res 29 2520-2526
[2]  
Looker AC(2007)Residual lifetime risk of fractures in women and men J Bone Miner Res 22 781-788
[3]  
Saag KG(2011)Medical costs of osteoporosis in the elderly Medicare population Osteoporos Int 22 1835-1844
[4]  
Curtis JR(2016)High rate of non-treatment among osteoporotic women enrolled in a US Medicare plan Curr Med Res Opin 32 1849-1856
[5]  
Delzell ES(2014)Clinician’s guide to prevention and treatment of osteoporosis Osteoporos Int 25 2359-2381
[6]  
Randall S(2016)Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 31 16-35
[7]  
Dawson-Hughes B(2019)A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk Osteoporos Int 30 705-720
[8]  
Nguyen ND(2006)Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention Trial long-term extension (FLEX): a randomized trial JAMA 296 2927-2938
[9]  
Ahlborg HG(2000)Vertebral fracture definition from population-based data: preliminary results from the Canadian multicenter osteoporosis study (CaMos) Osteoporos Int 11 680-687
[10]  
Center JR(2012)Lumbar spine and proximal femur bone mineral density, bone mineral content, and bone area: United States, 2005-2008 Vital Health Stat 11 1-132